These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7145656)

  • 1. [Cardiovascular diseases and lipid abnormalities in Cushing's syndrome].
    Luton JP; Richard C; Laudat MH; Pinon JC; Bricaire H
    Nouv Presse Med; 1982 Sep; 11(36):2693-8. PubMed ID: 7145656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of vascular function in hypertension due to Cushing's syndrome.
    Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R
    Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines.
    Mancini T; Kola B; Mantero F; Boscaro M; Arnaldi G
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):768-77. PubMed ID: 15579193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategy in the hypertension of Cushing's disease].
    Vidal-Trecan G; Luton JP; Mouveroux F; Bricaire H
    Ann Med Interne (Paris); 1983; 134(3):249-50. PubMed ID: 6625422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of arterial hypertension in Cushing's syndrome].
    Rodrigues D; Barros L; Ruas L; Gomes L; Geraldes E; Ruas MC
    Acta Med Port; 1997 Nov; 10(11):785-7. PubMed ID: 9549109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dawn hypertension in pre-Cushing's syndrome: report of two cases].
    Hayashi T; Yamauchi A; Hosoda K; Kakehi R
    Hinyokika Kiyo; 1994 Jul; 40(7):597-600. PubMed ID: 8085520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of endocrine hypertension experience in India.
    Dorairajan N; Pardhasaradhi K; Sivakumar S; Kannan MS; Velmurugan S
    J Indian Med Assoc; 1999 Jun; 97(6):233-6, 240. PubMed ID: 10645697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinico-pathological study of Cushing's syndrome at the University Hospital of the West Indies and a review of the literature.
    Wright-Pascoe R; Charles CF; Richards R; Fletcher P; Hanchard B; Kelly D
    West Indian Med J; 2001 Mar; 50(1):55-61. PubMed ID: 11398290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ketoconazole in the control of arterial hypertension in Cushing's syndrome].
    Calvo Romero JM; Morales Pérez F; Alvarez Barreiro JA; Díaz Pérez de Madrid J
    Rev Clin Esp; 1999 Jan; 199(1):25-7. PubMed ID: 10089773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cushing's syndrome: review of a national caseload].
    Contreras P; Araya V
    Rev Med Chil; 1995 Mar; 123(3):350-62. PubMed ID: 8525177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in Cushing's syndrome.
    Magiakou MA; Smyrnaki P; Chrousos GP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):467-82. PubMed ID: 16980206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral macronodular adrenal hyperplasia as an unusual cause of Cushing's syndrome--a case study.
    Agboola-Abu CF; Garba MR; Elesha SO; Obiora AA; Kuku SF
    West Afr J Med; 1999; 18(2):124-9. PubMed ID: 10504870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we evaluate for cardiovascular disease in patients with Cushing's syndrome?
    Fallo F; Sonino N
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):768-71. PubMed ID: 19508589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality characteristics and quality of life in patients treated for Cushing's syndrome.
    Sonino N; Bonnini S; Fallo F; Boscaro M; Fava GA
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):314-8. PubMed ID: 16487442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trial treatment of Cushing's syndrome with OP'DDD in children].
    Canlorbe P; Vassal J; Job JC
    Therapeutique; 1972 Apr; 48(4):319-26. PubMed ID: 5073104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lipid metabolism in Cushing's syndrome].
    Yoshida C; Miyachi Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():177-80. PubMed ID: 11347053
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trial treatment of Cushing's syndrome with OP'DDD in children].
    Canlorbe P; Vassal J; Job JC
    Ann Pediatr (Paris); 1971 Oct; 18(10):609-16. PubMed ID: 5126454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.